Investigating the effect of vitamin E in the prevention of kidney dysfunction in infants
Phase 3
- Conditions
- Acute kidney failure.Acute kidney failure
- Registration Number
- IRCT20221220056875N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Hospitalized in the neonatal intensive care unit
Weight more than 1000 grams
Not having any congenital or chromosomal abnormalities
Exclusion Criteria
Allergy to vitamin E
Contraindications for vitamin E use
Lack of consent to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Creatinine. Timepoint: before the treatment and on the second, fourth and sixth days after starting the treatment. Method of measurement: Blood sampling is done from the patients and the creatinine level is determined by a laboratory kit.
- Secondary Outcome Measures
Name Time Method